• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用组学技术鉴定心力衰竭的新型治疗靶点。

Using Omics to Identify Novel Therapeutic Targets in Heart Failure.

机构信息

Center for Pharmacogenomics and Precision Medicine, Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, FL.

出版信息

Circ Genom Precis Med. 2024 Jun;17(3):e004398. doi: 10.1161/CIRCGEN.123.004398. Epub 2024 May 20.

DOI:10.1161/CIRCGEN.123.004398
PMID:38766848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11187651/
Abstract

Omics refers to the measurement and analysis of the totality of molecules or biological processes involved within an organism. Examples of omics data include genomics, transcriptomics, epigenomics, proteomics, metabolomics, and more. In this review, we present the available literature reporting omics data on heart failure that can inform the development of novel treatments or innovative treatment strategies for this disease. This includes polygenic risk scores to improve prediction of genomic data and the potential of multiomics to more efficiently identify potential treatment targets for further study. We also discuss the limitations of omic analyses and the barriers that must be overcome to maximize the utility of these types of studies. Finally, we address the current state of the field and future opportunities for using multiomics to better personalize heart failure treatment strategies.

摘要

组学是指对生物体内部涉及的所有分子或生物过程的测量和分析。组学数据的例子包括基因组学、转录组学、表观基因组学、蛋白质组学、代谢组学等。在这篇综述中,我们呈现了可用于心力衰竭的组学数据的现有文献,这些数据可以为这种疾病的新疗法或创新治疗策略的发展提供信息。这包括多基因风险评分以提高对基因组数据的预测,以及多组学在更有效地识别潜在治疗靶点以进一步研究方面的潜力。我们还讨论了组学分析的局限性以及必须克服的障碍,以最大限度地提高这类研究的效用。最后,我们讨论了该领域的现状以及使用多组学更好地实现心力衰竭治疗策略个体化的未来机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2afb/11187651/f758c7c5c2df/nihms-1992547-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2afb/11187651/f758c7c5c2df/nihms-1992547-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2afb/11187651/f758c7c5c2df/nihms-1992547-f0001.jpg

相似文献

1
Using Omics to Identify Novel Therapeutic Targets in Heart Failure.利用组学技术鉴定心力衰竭的新型治疗靶点。
Circ Genom Precis Med. 2024 Jun;17(3):e004398. doi: 10.1161/CIRCGEN.123.004398. Epub 2024 May 20.
2
Drug Discovery and Development for Heart Failure Using Multi-Omics Approaches.使用多组学方法进行心力衰竭的药物发现与开发。
Int J Mol Sci. 2025 Mar 17;26(6):2703. doi: 10.3390/ijms26062703.
3
Cardiac Fibrosis in the Multi-Omics Era: Implications for Heart Failure.多组学时代的心脏纤维化:对心力衰竭的影响
Circ Res. 2025 Mar 28;136(7):773-802. doi: 10.1161/CIRCRESAHA.124.325402. Epub 2025 Mar 27.
4
Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association.精准医疗时代的心力衰竭:美国心脏协会的科学声明。
Circ Genom Precis Med. 2019 Oct;12(10):458-485. doi: 10.1161/HCG.0000000000000058. Epub 2019 Sep 12.
5
Multi-omics approaches for biomarker discovery and precision diagnosis of prediabetes.用于糖尿病前期生物标志物发现和精准诊断的多组学方法。
Front Endocrinol (Lausanne). 2025 Mar 14;16:1520436. doi: 10.3389/fendo.2025.1520436. eCollection 2025.
6
404-error "Disease not found": Unleashing the translational potential of -omics approaches beyond traditional disease classification in heart failure research.404 错误“未发现疾病”:在心力衰竭研究中超越传统疾病分类,释放组学方法的转化潜力。
Eur J Heart Fail. 2024 Jun;26(6):1313-1323. doi: 10.1002/ejhf.3268. Epub 2024 May 13.
7
Genomics and multiomics in the age of precision medicine.精准医学时代的基因组学与多组学
Pediatr Res. 2025 Apr 4. doi: 10.1038/s41390-025-04021-0.
8
Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.多组学数据的三角剖分在哮喘候选生物标志物和精准医学中的应用
OMICS. 2018 Jun;22(6):392-409. doi: 10.1089/omi.2018.0036.
9
Harnessing omics data for drug discovery and development in ovarian aging.利用组学数据进行卵巢衰老的药物发现与开发。
Hum Reprod Update. 2025 May 1;31(3):240-268. doi: 10.1093/humupd/dmaf002.
10
The Need for Multi-Omics Biomarker Signatures in Precision Medicine.精准医学中多组学生物标志物特征的必要性。
Int J Mol Sci. 2019 Sep 26;20(19):4781. doi: 10.3390/ijms20194781.

引用本文的文献

1
Physical activity and glioblastoma: a paradigm shift in neuro-oncology therapy.体育活动与胶质母细胞瘤:神经肿瘤学治疗的范式转变
Front Oncol. 2025 Jul 30;15:1638060. doi: 10.3389/fonc.2025.1638060. eCollection 2025.

本文引用的文献

1
Accurate proteome-wide missense variant effect prediction with AlphaMissense.使用 AlphaMissense 进行精确的全蛋白质错义变异效应预测。
Science. 2023 Sep 22;381(6664):eadg7492. doi: 10.1126/science.adg7492.
2
Common Variants on Increase Hazard of Mortality or Rehospitalization in Patients With Heart Failure From the ASCEND-HF Trial.常见变异可增加 ASCEND-HF 试验心衰患者的死亡率或再住院风险。
Circ Heart Fail. 2023 Sep;16(9):e010438. doi: 10.1161/CIRCHEARTFAILURE.122.010438. Epub 2023 Jul 26.
3
Protocatechuic acid prevents isoproterenol-induced heart failure in mice by downregulating kynurenine-3-monooxygenase.
原儿茶酸通过下调犬尿氨酸 3-单加氧酶预防异丙肾上腺素诱导的小鼠心力衰竭。
J Cell Mol Med. 2023 Aug;27(16):2290-2307. doi: 10.1111/jcmm.17869. Epub 2023 Jul 22.
4
Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure.全基因组关联分析和孟德尔随机化蛋白质组学鉴定心力衰竭的药物靶点。
Nat Commun. 2023 Jul 10;14(1):3826. doi: 10.1038/s41467-023-39253-3.
5
A novel polygenic risk score improves prognostic prediction of heart failure with preserved ejection fraction in the Chinese Han population.一种新的多基因风险评分可改善中国汉族人心力衰竭保留射血分数患者的预后预测。
Eur J Prev Cardiol. 2023 Sep 20;30(13):1382-1390. doi: 10.1093/eurjpc/zwad209.
6
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study.新发性心力衰竭的蛋白质生物标志物:来自心脏组学和衰老队列、社区动脉粥样硬化风险研究和弗雷明汉心脏研究的见解。
Circ Heart Fail. 2023 May;16(5):e009694. doi: 10.1161/CIRCHEARTFAILURE.122.009694. Epub 2023 May 16.
7
The Implication of the Gut Microbiome in Heart Failure.肠道微生物组在心力衰竭中的意义。
Cells. 2023 Apr 14;12(8):1158. doi: 10.3390/cells12081158.
8
Proteomics and phosphoproteomics of failing human left ventricle identifies dilated cardiomyopathy-associated phosphorylation of CTNNA3.人衰竭左心室的蛋白质组学和磷酸化蛋白质组学鉴定出与扩张型心肌病相关的 CTNNA3 磷酸化。
Proc Natl Acad Sci U S A. 2023 May 9;120(19):e2212118120. doi: 10.1073/pnas.2212118120. Epub 2023 May 1.
9
Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity.影响心脏结构和功能的可药物化蛋白:对心力衰竭治疗和癌症心脏毒性的影响。
Sci Adv. 2023 Apr 28;9(17):eadd4984. doi: 10.1126/sciadv.add4984. Epub 2023 Apr 26.
10
Applications of single-cell RNA sequencing in drug discovery and development.单细胞 RNA 测序在药物发现和开发中的应用。
Nat Rev Drug Discov. 2023 Jun;22(6):496-520. doi: 10.1038/s41573-023-00688-4. Epub 2023 Apr 28.